New York Genome Center

For decades, government funding “has positioned the United States as a global leader” in science, says scientist Tom Maniatis of Columbia’s Zuckerman Institute and the New York Genome Center. He highlights how a new National Institutes of Health policy cutting money for research “jeopardizes” this, in Cell Press: https://lnkd.in/e829EjcV See our related animation on these NIH funds: https://lnkd.in/e4iWAgGT

If you're attending the 2025 ACMG - American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting at the Los Angeles Convention Center, don't miss the session "Advances in the Clinical and Laboratory Approaches to Repeat Expansion Disorders." This first-of-its-kind ACMG session is dedicated exclusively to Repeat Expansion Disorders and aims to provide clinicians and laboratory professionals with cutting-edge updates on diagnosing and detecting repeat expansions using advanced sequencing technologies. Key highlights of the session include: 1. Latest advancements in sequencing technologies for repeat expansion detection 2. Newly developed databases and their role in analyzing complex repeat alleles 3. Case studies showcasing real-world applications, challenges, and best practices in testing 4. Guidance on follow-up criteria for clinical management after test results Join us for an engaging discussion led by renowned experts in the field, covering both clinical and laboratory perspectives on repeat expansion disorders. This session is a must-attend for anyone involved in genetic diagnostics, clinical care, or research on repeat expansions. We look forward to seeing you there! #gemomics #genetics #genomesequencing #healthcare #geneticdiagnosis

Dr. Harold Varmus, a former director of the National Institutes of Health (NIH) and Senior Associate Member of the New York Genome Center, joined Science Friday to discuss the effects of the recent cuts to NIH staff and funding. Listen here: https://bit.ly/427hAIz

Enjoyed participating in this far-ranging podcast about CRISPR and genome editing and its transformative impact on human health —?and even more important in these challenging times. Thanks to The Naked Scientists for the opportunity to discuss and share our work.

We proudly recognize the 54 Nobel Laureates who have signed the NYGC’s petition urging NIH to reverse its recent policy change capping indirect funds. Thank you for your support and commitment to advancing scientific research at institutions nationwide. https://lnkd.in/e9vMCp8s

Following the NIH decision to cap funding for indirect cost reimbursements at 15%, New York Genome Center Scientific Director Tom Maniatis calls for swift, united action. Read his Commentary now in Cell by Cell Press: https://lnkd.in/eknB_2dp

UNDERLYING BIOLOGY: Tuuli Lappalainen from New York Genome Center takes the stage at the 2025 AGBT - Advances in Genome Biology and Technology General Meeting to detail functional variation in the genome and lessons from natural and experimental perturbations. #AGBTGM

DAY 2 JUST AHEAD: Richard Lifton from The Rockefeller University, Tuuli Lappalainen from New York Genome Center, Richard Gibbs from Baylor College of Medicine, Krystal Tsosie from Arizona State University & Corrie Painter from the Broad Institute of MIT and Harvard lead a spectacular day at the 2025 AGBT - Advances in Genome Biology and Technology General Meeting. #AGBTGM

NIH's new policy (NOT-OD-25-068) capping indirect cost reimbursement at 15% threatens the future of research, training, and scientific infrastructure at research institutions nationwide. In response, the NYGC has drafted a petition urging its reversal. Please join us by signing and circulating this petition within your networks. https://chng.it/mL7jNwh5fk